I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 26% ± 10% | |
| smooth muscle cell | 11 studies | 26% ± 8% | |
| pericyte | 10 studies | 23% ± 5% | |
| natural killer cell | 8 studies | 19% ± 4% | |
| capillary endothelial cell | 8 studies | 20% ± 7% | |
| endothelial cell of artery | 7 studies | 21% ± 3% | |
| endothelial cell of vascular tree | 7 studies | 21% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 3% | |
| epithelial cell | 4 studies | 33% ± 8% | |
| vein endothelial cell | 4 studies | 26% ± 8% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 5% | |
| basal cell | 4 studies | 27% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 2% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 21% ± 5% | |
| ciliated cell | 3 studies | 22% ± 2% | |
| gamma-delta T cell | 3 studies | 20% ± 3% |
